These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 9930345)

  • 21. B Cell-Specific Transcription Activator PAX5 Recruits p300 To Support EBNA1-Driven Transcription.
    Liu CD; Lee HL; Peng CW
    J Virol; 2020 Mar; 94(7):. PubMed ID: 31941781
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HCF1 and OCT2 Cooperate with EBNA1 To Enhance OriP-Dependent Transcription and Episome Maintenance of Latent Epstein-Barr Virus.
    Dheekollu J; Wiedmer A; Sentana-Lledo D; Cassel J; Messick T; Lieberman PM
    J Virol; 2016 Jun; 90(11):5353-5367. PubMed ID: 27009953
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The linking regions of EBNA1 are essential for its support of replication and transcription.
    Mackey D; Sugden B
    Mol Cell Biol; 1999 May; 19(5):3349-59. PubMed ID: 10207059
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An origin of DNA replication (oriP) in highly methylated episomal Epstein-Barr virus DNA localizes to a 4.5-kb unmethylated region.
    Falk K; Ernberg I
    Virology; 1993 Aug; 195(2):608-15. PubMed ID: 8393238
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metaphase chromosome tethering is necessary for the DNA synthesis and maintenance of oriP plasmids but is insufficient for transcription activation by Epstein-Barr nuclear antigen 1.
    Sears J; Kolman J; Wahl GM; Aiyar A
    J Virol; 2003 Nov; 77(21):11767-80. PubMed ID: 14557661
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sustained transgene expression in vitro and in vivo using an Epstein-Barr virus replicon vector system combined with HVJ liposomes.
    Saeki Y; Wataya-Kaneda M; Tanaka K; Kaneda Y
    Gene Ther; 1998 Aug; 5(8):1031-7. PubMed ID: 10326025
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Requirement of replication licensing for the dyad symmetry element-dependent replication of the Epstein-Barr virus oriP minichromosome.
    Shirakata M; Imadome KI; Hirai K
    Virology; 1999 Oct; 263(1):42-54. PubMed ID: 10544081
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stable transduction of actively dividing cells via a novel adenoviral/episomal vector.
    Leblois H; Roche C; Di Falco N; Orsini C; Yeh P; Perricaudet M
    Mol Ther; 2000 Apr; 1(4):314-22. PubMed ID: 10933949
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhancement of transgene expression by cotransfection of oriP plasmid with EBNA-1 expression vector.
    Kaneda Y; Saeki Y; Nakabayashi M; Zhou WZ; Kaneda MW; Morishita R
    Hum Gene Ther; 2000 Feb; 11(3):471-9. PubMed ID: 10697121
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficient method for expressing transgenes in nonhuman primate embryos using a stable episomal vector.
    Wolfgang MJ; Marshall VS; Eisele SG; Schotzko ML; Thomson JA; Golos TG
    Mol Reprod Dev; 2002 May; 62(1):69-73. PubMed ID: 11933162
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Up to 100-fold increase of apparent gene expression in the presence of Epstein-Barr virus oriP sequences and EBNA1: implications of the nuclear import of plasmids.
    Längle-Rouault F; Patzel V; Benavente A; Taillez M; Silvestre N; Bompard A; Sczakiel G; Jacobs E; Rittner K
    J Virol; 1998 Jul; 72(7):6181-5. PubMed ID: 9621086
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ribosome Protein L4 is essential for Epstein-Barr Virus Nuclear Antigen 1 function.
    Shen CL; Liu CD; You RI; Ching YH; Liang J; Ke L; Chen YL; Chen HC; Hsu HJ; Liou JW; Kieff E; Peng CW
    Proc Natl Acad Sci U S A; 2016 Feb; 113(8):2229-34. PubMed ID: 26858444
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeted killing of carcinoembryonic antigen (CEA)-producing cholangiocarcinoma cells by polyamidoamine dendrimer-mediated transfer of an Epstein-Barr virus (EBV)-based plasmid vector carrying the CEA promoter.
    Tanaka S; Iwai M; Harada Y; Morikawa T; Muramatsu A; Mori T; Okanoue T; Kashima K; Maruyama-Tabata H; Hirai H; Satoh E; Imanishi J; Mazda O
    Cancer Gene Ther; 2000 Sep; 7(9):1241-50. PubMed ID: 11023196
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epstein-Barr Nuclear Antigen 1 modulates replication of oriP-plasmids by impeding replication and transcription fork migration through the family of repeats.
    Aiyar A; Aras S; Washington A; Singh G; Luftig RB
    Virol J; 2009 Mar; 6():29. PubMed ID: 19265546
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gene therapy progress and prospects: episomally maintained self-replicating systems.
    Conese M; Auriche C; Ascenzioni F
    Gene Ther; 2004 Dec; 11(24):1735-41. PubMed ID: 15385951
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cryo-EM Structure and Functional Studies of EBNA1 Binding to the Family of Repeats and Dyad Symmetry Elements of Epstein-Barr Virus
    Mei Y; Messick TE; Dheekollu J; Kim HJ; Molugu S; Muñoz LJC; Moiskeenkova-Bell V; Murakami K; Lieberman PM
    J Virol; 2022 Sep; 96(17):e0094922. PubMed ID: 36037477
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of Epstein-Barr virus OriP function by tankyrase, a telomere-associated poly-ADP ribose polymerase that binds and modifies EBNA1.
    Deng Z; Atanasiu C; Zhao K; Marmorstein R; Sbodio JI; Chi NW; Lieberman PM
    J Virol; 2005 Apr; 79(8):4640-50. PubMed ID: 15795250
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Maintenance of Epstein-Barr virus-derived episomal vectors in the murine Sp2/0 myeloma cell line is dependent upon exogenous expression of human EBP2.
    Habel ME; Drouin M; Jung D
    Biochem Cell Biol; 2004 Jun; 82(3):375-80. PubMed ID: 15181471
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epstein-Barr virus-derived vectors for transient and stable expression of recombinant proteins.
    Cachianes G; Ho C; Weber RF; Williams SR; Goeddel DV; Leung DW
    Biotechniques; 1993 Aug; 15(2):255-9. PubMed ID: 8396947
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lytic cycle gene regulation of Epstein-Barr virus.
    Amon W; Binné UK; Bryant H; Jenkins PJ; Karstegl CE; Farrell PJ
    J Virol; 2004 Dec; 78(24):13460-9. PubMed ID: 15564457
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.